These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21532920)

  • 21. Co-occurring mental and substance use disorders: promising approaches and research issues.
    Sacks S
    Subst Use Misuse; 2000; 35(12-14):2061-93. PubMed ID: 11138717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of three interventions for substance abuse treatment of severely mentally ill people.
    Ridgely MS; Jerrell JM
    Community Ment Health J; 1996 Dec; 32(6):561-72. PubMed ID: 8905228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials.
    Donald M; Dower J; Kavanagh D
    Soc Sci Med; 2005 Mar; 60(6):1371-83. PubMed ID: 15626531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interagency collaboration in services for people with co-occurring mental illness and substance use disorder.
    Ridgely MS; Lambert D; Goodman A; Chichester CS; Ralph R
    Psychiatr Serv; 1998 Feb; 49(2):236-8. PubMed ID: 9575013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosocial interventions for people with both severe mental illness and substance misuse.
    Hunt GE; Siegfried N; Morley K; Sitharthan T; Cleary M
    Cochrane Database Syst Rev; 2013 Oct; (10):CD001088. PubMed ID: 24092525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assertive community treatment for elderly people with severe mental illness.
    Stobbe J; Mulder NC; Roosenschoon BJ; Depla M; Kroon H
    BMC Psychiatry; 2010 Oct; 10():84. PubMed ID: 20958958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospitalisation of severely mentally ill patients with and without problematic substance use before and during Assertive Community Treatment: an observational cohort study.
    Clausen H; Ruud T; Odden S; Šaltytė Benth J; Heiervang KS; Stuen HK; Killaspy H; Drake RE; Landheim A
    BMC Psychiatry; 2016 May; 16():125. PubMed ID: 27145937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WITHDRAWN: Assertive community treatment for people with severe mental disorders.
    Marshall M; Lockwood A
    Cochrane Database Syst Rev; 2011 Apr; 2011(4):CD001089. PubMed ID: 21491382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Mueser KT; Drake RE
    Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study.
    McHugo GJ; Drake RE; Teague GB; Xie H
    Psychiatr Serv; 1999 Jun; 50(6):818-24. PubMed ID: 10375153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of consumer-provided services on assertive community treatment and intensive case management teams: implications for future research and practice.
    Wright-Berryman JL; McGuire AB; Salyers MP
    J Am Psychiatr Nurses Assoc; 2011; 17(1):37-44. PubMed ID: 21659293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mental health services: critical component of integrated primary care and substance abuse treatment.
    Brach C; Falik M; Law C; Robinson G; Trent-Adams S; Ulmer C; Wright A
    J Health Care Poor Underserved; 1995; 6(3):322-41. PubMed ID: 7548490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assertive community treatment: an update of randomized trials.
    Burns BJ; Santos AB
    Psychiatr Serv; 1995 Jul; 46(7):669-75. PubMed ID: 7552556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substance abuse in a Canadian population of Assertive Community Treatment (ACT) clients: implications for service planning and delivery.
    Eastabrook S; Krupa T; Horgan S; Gerber G; Grant R; Mayo J; Leeder M; Stiemerling N
    Can J Nurs Res; 2003 Mar; 35(1):44-51. PubMed ID: 12854240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Integrated Intervention for Dual Problems and Early Action Among Latino Immigrants With Co-occurring Mental Health and Substance Misuse Symptoms: A Randomized Clinical Trial.
    Alegría M; Falgas-Bague I; Collazos F; Carmona Camacho R; Lapatin Markle S; Wang Y; Baca-García E; Lê Cook B; Chavez LM; Fortuna L; Herrera L; Qureshi A; Ramos Z; González C; Aroca P; Albarracín García L; Cellerino L; Villar A; Ali N; Mueser KT; Shrout PE
    JAMA Netw Open; 2019 Jan; 2(1):e186927. PubMed ID: 30646205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for drug-using offenders with co-occurring mental illness.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2014 Jan; (1):CD010901. PubMed ID: 24385324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
    Jerrell JM; Ridgely MS
    J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.